KromaTiD adds Surefire Medical founder to board
LONGMONT — Biotechnology firm KromaTiD Inc. has added James Chomas, medical device firm Surefire Medical Inc.’s founder, to its board of directors.
Chomas joins KromaTiD as the firm aims to accelerate commercialization of its genomic structural services.
“KromaTiD has developed an important and innovative advancement in understanding the integrity of the genome, which has broad applications in supporting CRISPR therapy development, uncovering genetic causes of undiagnosed diseases, and cancer diagnostics,” Chomas said in a prepared statement. “I’m honored to join the board and to partner with the KromaTiD team to drive commercial success in this exciting period of gene editing advancement.”
SPONSORED CONTENT
Select your Republic Services residential cart now!
In preparation for Republic Services becoming the primary provider of residential recycling, yard trimmings, and trash, residents should now select the best cart size and service schedule for their household needs.
© 2021 BizWest Media LLC
LONGMONT — Biotechnology firm KromaTiD Inc. has added James Chomas, medical device firm Surefire Medical Inc.’s founder, to its board of directors.
Chomas joins KromaTiD as the firm aims to accelerate commercialization of its genomic structural services.
“KromaTiD has developed an important and innovative advancement in understanding the integrity of the genome, which has broad applications in supporting CRISPR therapy development, uncovering genetic causes of undiagnosed diseases, and cancer diagnostics,” Chomas said in a prepared statement. “I’m honored to join the board and to partner with the KromaTiD team to drive commercial success in this exciting…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!